Novartis
NVS
#57
Rank
HK$1.974 T
Marketcap
HK$1,029
Share price
-0.20%
Change (1 day)
33.76%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$486.82 Billion

According to Novartis's latest financial reports the company's total liabilities are HK$486.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novartis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$451.21 B8.61%
2023-12-31HK$415.45 B-8.37%
2022-12-31HK$453.40 B-9.11%
2021-12-31HK$498.83 B-9.51%
2020-12-31HK$551.27 B12.68%
2019-12-31HK$489.24 B-6.57%
2018-12-31HK$523.66 B13.89%
2017-12-31HK$459.80 B7.35%
2016-12-31HK$428.30 B1.52%
2015-12-31HK$421.90 B-0.27%
2014-12-31HK$423.06 B5.36%
2013-12-31HK$401.53 B-5.69%
2012-12-31HK$425.75 B6.33%
2011-12-31HK$400.43 B-3.91%
2010-12-31HK$416.72 B41.28%
2009-12-31HK$294.97 B37%
2008-12-31HK$215.30 B5.98%
2007-12-31HK$203.15 B-2.22%
2006-12-31HK$207.76 B9.07%
2005-12-31HK$190.48 B15.77%
2004-12-31HK$164.53 B12.92%
2003-12-31HK$145.70 B11.95%
2002-12-31HK$130.15 B13.19%
2001-12-31HK$114.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
HK$604.38 B 24.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 84.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 81.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$513.99 B 5.58%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$477.07 B-2.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$253.79 B-47.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
HK$609.44 B 25.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$256.24 B-47.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$533.12 B 9.51%๐Ÿ‡ฌ๐Ÿ‡ง UK